| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute on Drug Abuse (NIDA) |
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00000202 |
Purpose
The purpose of this study is to evaluate the efficacy of buprenorphine and desipramine in treatment of opiate and cocaine dependence.
| Condition | Intervention | Phase |
|
Opioid-Related Disorders |
Drug: Buprenorphine |
Phase II |
| Drug Information available for: | Buprenorphine Buprenorphine hydrochloride |
| Study Type: | Interventional |
| Study Design: | Treatment, Uncontrolled |
| Official Title: | Buprenorphine Maintenance for Opioid Addicts |
Eligibility
| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Please contact site for information.
Contacts and Locations| United States, Connecticut | |||||
| VA Connecticut Healthcare System | |||||
| New Haven, Connecticut, United States, 06519 | |||||
| Principal Investigator: | Thomas R Kosten, M.D. | VA Connecticut Healthcare System |
More Information
|
J Nerv Mental Dis, 1993, 181(6) pp. 358-364; NIDA Res Mono 1993, 132:100 ; Am J Psychiatary 1993, 150:1755; Am J Addictions 1994, 3: 43-48; NIDA Res Mono 1994, 141:79; NIDA Res Mono 1995, in press.
|
| Study ID Numbers: | NIDA-05626-1, R01-05626-1 |
| First Received: | September 20, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00000202 |
| Health Authority: | United States: Federal Government |
|
|
|
|
